Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Blendis

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Blood|May 15, 1992
Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermediaN F Olivieri, G Koren, D Matsui, et al.
Bone Marrow Transplantation|January 1, 1993
Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patientsN F Olivieri, D Matsui, P P Liu, et al.
Transplantation|July 27, 1994
Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantationM Flowers, A Sherker, S B Sinclair, et al.
Hepatology (Baltimore, Md.)|July 1, 1990
The demography of primary biliary cirrhosis in Ontario, CanadaH Witt-Sullivan, J Heathcote, K Cauch, et al.
Transplantation Proceedings|February 1, 1989
Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survivalP D Greig, G M Woolf, M Abecassis, et al.
Transplantation Proceedings|June 1, 1988
Conjugated and delta bilirubin determinations in early liver allograft rejectionT W Wu, J X Au, P D Greig, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Blood|May 15, 1992
Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermediaN F Olivieri, G Koren, D Matsui, et al.
Bone Marrow Transplantation|January 1, 1993
Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patientsN F Olivieri, D Matsui, P P Liu, et al.
Transplantation|July 27, 1994
Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantationM Flowers, A Sherker, S B Sinclair, et al.
Hepatology (Baltimore, Md.)|July 1, 1990
The demography of primary biliary cirrhosis in Ontario, CanadaH Witt-Sullivan, J Heathcote, K Cauch, et al.
Transplantation Proceedings|February 1, 1989
Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survivalP D Greig, G M Woolf, M Abecassis, et al.
Transplantation Proceedings|June 1, 1988
Conjugated and delta bilirubin determinations in early liver allograft rejectionT W Wu, J X Au, P D Greig, et al.
Pageof 7